VRNA
Verona Pharma
VRNA
VRNA
Delisted
VRNA was delisted on the 6th of October, 2025.
40 hedge funds and large institutions have $122M invested in Verona Pharma in 2022 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
40
Holders Change
+1
Holders Change %
+2.56%
% of All Funds
0.68%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
9
Increased
6
Reduced
4
Closed
8
Calls
$388K
Puts
–
Net Calls
+$388K
Net Calls Change
+$309K
Top Buyers
Top Sellers
1 |
GTC
Ghost Tree Capital
New York
|
-$3.74M |
2 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$3.33M |
3 |
Citigroup
New York
|
-$1.84M |
4 |
LGM
Logos Global Management
San Francisco,
California
|
-$1.5M |
5 |
PA
Perceptive Advisors
New York
|
-$541K |